A 2‐year review of publicly funded cell‐free DNA screening in Ontario: utilization and adherence to funding criteria-Reference-Cited by-同舟云学术

A 2‐year review of publicly funded cell‐free DNA screening in Ontario: utilization and adherence to funding criteria

Published:2019-11-21 Issue:2 Volume:40 Page:164-172
ISSN:0197-3851
Container-title:Prenatal Diagnosis
language:en
Short-container-title:Prenatal Diagnosis

Author:

Bellai‐Dussault Kara¹²^ORCID,Meng Lynn¹,Huang Tianhua¹³⁴,Reszel Jessica¹²^ORCID,Walker Mark¹²⁵⁶,Lanes Andrea¹,Okun Nan¹⁷,Armour Christine¹²⁸,Dougan Shelley¹²

Affiliation:

1. Better Outcomes Registry & Network (BORN) Ontario Ottawa Ontario Canada

2. Children's Hospital of Eastern Ontario (CHEO) Research Institute Ottawa Ontario Canada

3. North York General Hospital Toronto Ontario Canada

4. The Institute of Health Policy, Management and Evaluation & Department of Obstetrics & GynaecologyUniversity of Toronto Toronto Ontario Canada

5. The Ottawa Hospital Ottawa Ontario Canada

6. Ottawa Hospital Research Institute (OHRI) Ottawa Ontario Canada

7. Mount Sinai Hospital Toronto Ontario Canada

8. Children's Hospital of Eastern Ontario (CHEO) Ottawa Ontario Canada

Publisher

Wiley

Subject

Genetics(clinical),Obstetrics and Gynaecology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pd.5563

Reference38 articles.

1. Trends in the use of prenatal testing services for fetal aneuploidy in Ontario: a descriptive study

2. Non-invasive prenatal testing: a review of international implementation and challenges

3. Varela‐LemaL Puñal‐RiobóoJ BalliniL.Screening of fetal trisomies 21 18 and 13 by noninvasive prenatal testing (EUnetHTA Project ID: OTCA03).2018.https://www.eunethta.eu/wp‐content/uploads/2018/03/OTCA03_Screening‐of‐fetal‐trisomies‐21‐18‐and‐13‐by‐noninvasive‐prenatal‐testing_V1.5.pdf. Accessed June 3 2019.

4. Centrum voor Medische Genetica.Prenatal examinations ‐ NIPT.2018.http://www.brusselsgenetics.be/nipt‐en?doscroll=true#NavL3. Accessed April 25 2019.

5. Implementing non-invasive prenatal testing into publicly funded antenatal screening services for Down syndrome and other conditions in Aotearoa New Zealand

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. First and second trimester maternal serum markers for prenatal aneuploidy screening: An update on the adjustment factors for race, smoking, and insulin dependent diabetes mellitus;Clinical Biochemistry;2023-08

2. Cytogenetic outcomes following a failed cell-free DNA screen: a population-based retrospective cohort study of 35,146 singleton pregnancies;American Journal of Obstetrics and Gynecology;2023-08

3. The impact of maternal and geographical factors on the uptake of non‐invasive prenatal testing: A retrospective cohort study;Prenatal Diagnosis;2022-11-07

4. Factors involved in the decision to decline prenatal screening with noninvasive prenatal testing (NIPT);Prenatal Diagnosis;2022-09-23

5. A Cost-Effectiveness Analysis of Screening Strategies Involving Non-Invasive Prenatal Testing for Trisomy 21;Frontiers in Public Health;2022-05-31